As we do not know the precise role of cytosolic PINK1 versus mitochondrial PINK1 in ER + breast cancer, we cannot exclude the possibility of both cytosolic and mitochondrial PINK1 contributing to the antiestrogen resistance phenotype. This evidence concerns the gene PINK1 and breast carcinoma.